These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26230938)

  • 21. Rational Design of a Glycoconjugate Vaccine against Group A
    Di Benedetto R; Mancini F; Carducci M; Gasperini G; Moriel DG; Saul A; Necchi F; Rappuoli R; Micoli F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
    Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
    J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving vaccines against
    Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
    [No Abstract]   [Full Text] [Related]  

  • 25. Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides.
    Gallorini S; Berti F; Mancuso G; Cozzi R; Tortoli M; Volpini G; Telford JL; Beninati C; Maione D; Wack A
    Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17481-6. PubMed ID: 19805031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Sun X; Stefanetti G; Berti F; Kasper DL
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):193-198. PubMed ID: 30510007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
    Whang YH; Kim SK; Yoon H; Choi SK; Baik YO; Lee C; Lee I
    PLoS One; 2020; 15(12):e0243909. PubMed ID: 33301525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designer vaccines to prevent infections due to group B Streptococcus.
    Kasper DL
    Proc Assoc Am Physicians; 1995 Oct; 107(3):369-73. PubMed ID: 8608425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoconjugate vaccines: some observations on carrier and production methods.
    MacCalman TE; Phillips-Jones MK; Harding SE
    Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
    Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
    J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semisynthetic glycoconjugate based on dual role protein/PsaA as a pneumococcal vaccine.
    Prasanna M; Soulard D; Camberlein E; Ruffier N; Lambert A; Trottein F; Csaba N; Grandjean C
    Eur J Pharm Sci; 2019 Mar; 129():31-41. PubMed ID: 30572107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
    Santamaria R; Goulart C; Perciani CT; Barazzone GC; Carvalho R; Gonçalves VM; Leite LC; Tanizaki MM
    Vaccine; 2011 Nov; 29(47):8689-95. PubMed ID: 21906649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends.
    Micoli F; Adamo R; Costantino P
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
    Arcuri M; Di Benedetto R; Cunningham AF; Saul A; MacLennan CA; Micoli F
    PLoS One; 2017; 12(12):e0189100. PubMed ID: 29287062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide.
    Amir-Kroll H; Riveron L; Sarmiento ME; Sierra G; Acosta A; Cohen IR
    Vaccine; 2006 Oct; 24(42-43):6555-63. PubMed ID: 16843573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.
    Wessels MR; Paoletti LC; Guttormsen HK; Michon F; D'Ambra AJ; Kasper DL
    Infect Immun; 1998 May; 66(5):2186-92. PubMed ID: 9573106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
    Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
    Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.